Artisan Partners Asset (NYSE:APAM) reported quarterly earnings of $0.98 per share which missed the analyst consensus estimate of $1.03 by 4.85 percent. This is a 13.27 percent decrease over earnings of $1.13 per share from the same period last year.
Goldman Sachs Maintains Buy on Prometheus Biosciences, Raises Price Target to $144
Goldman Sachs analyst Chris Shibutani maintains Prometheus Biosciences (NASDAQ:RXDX) with a Buy and raises the price target from $117 to $144.
